l e t t e r s Genome-wide association studies have identified many genetic variants associated with complex traits. However, at only a minority of loci have the molecular mechanisms mediating these associations been characterized. In parallel, whereas cis regulatory patterns of gene expression have been extensively explored, the identification of trans regulatory effects in humans has attracted less attention. Here we show that the type 2 diabetes and high-density lipoprotein cholesterolassociated cis-acting expression quantitative trait locus (eQTL) of the maternally expressed transcription factor KLF14 acts as a master trans regulator of adipose gene expression. Expression levels of genes regulated by this trans-eQTL are highly correlated with concurrently measured metabolic traits, and a subset of the trans-regulated genes harbor variants directly associated with metabolic phenotypes. This trans-eQTL network provides a mechanistic understanding of the effect of the KLF14 locus on metabolic disease risk and offers a potential model for other complex traits.
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Variants near the maternally expressed transcription factor KLF14 (encoding Kruppel-like factor 14) are robustly associated with both type 2 diabetes (T2D) and high-density lipoprotein (HDL) cholesterol levels in large-scale genome-wide association studies (GWAS) 1, 2 . These studies have implicated a group of highly correlated SNPs, including rs4731702 and rs972283 located ~14 kb upstream of KLF14. KLF14 is the gene in the region likely to be mediating these effects, as the same SNPs show adipose-specific, maternally restricted cis-regulatory associations with KLF14 expression levels, a pattern that mirrors the parent-of-origin effects for T2D susceptibility at this locus 3 .
Because transcription factors such as KLF14 typically modulate expression of other genes in trans, we tested for association between rs4731702 and expression levels of ~24,000 probes (16,663 genes) on the Illumina Human HT12 array in subcutaneous adipose tissue biopsies from a cohort of 776 healthy female twins 4 . The enrichment of rs4731702 trans associations for low P values ( Fig. 1 and  Supplementary Fig. 1) suggests that KLF14 is a master regulator of gene expression in adipose tissue. The pattern of trans associations at KLF14 mirrors the GWAS associations ( Fig. 2 Figure 1 KLF14 is a master regulator of gene expression in adipose tissue. Shown is the P value distribution of association between the KLF14 cis-eQTL rs4731702 and expression levels of ~24,000 probes in adipose tissue. l e t t e r s Fig. 2) , and conditioning the trans associations on rs4731702 abolished the signal at all other SNPs. These findings indicate that the same set of SNPs (and presumably the same causal variant) underlies the cis, trans and metabolic trait associations at this locus. We focused on the ten genes (TPMT, ARSD, SLC7A10, C8orf82, APH1B, PRMT2, NINJ2, KLF13, GNB1 and MYL5) showing genomewide significant trans (GWST) associations (P < 5 × 10 −8 ) driven by rs4731702 ( Table 1) . First, we sought replication of the trans associations in an independent set of adipose tissue samples (deCODE genetics; n = 589) 5 . As previously reported 3 , the deCODE data showed a strong maternally specific cis association between rs4731702 and KLF14 expression in adipose tissue (P = 1 × 10 −19 ). We did not detect this cis effect in the MuTHER data because of apparent problems with the KLF14 probe represented on the Illumina HT12 array used for the MuTHER data (Online Methods). Seven of the GWST genes from the MuTHER analysis had a directionally consistent trans association with P < 0.05 in the deCODE replication set ( Table 1) , and we were able to show parent-of-origin effects for the trans associations consistent with the maternally specific cis effects for KLF14 expression and T2D risk 3 . In the deCODE replication data, maternally inherited trans associations were markedly more significant than general analyses, and we saw no paternally inherited trans associations ( Table 1) .
The trans effects explain a substantial portion of the genetically regulated variation in GWST expression levels. Our heritability estimates of GWST gene expression levels ranged from 0.13 to 0.79; the rs4731702 trans-eQTL explained between 3% and 7.8% of the variance in expression, corresponding to 6% to 25% of the heritability ( Table 2) . Expression levels of the ten GWST genes were moderately correlated in adipose tissue, with a mean |pairwise ρ| of 0.29 (standard deviation = 0.15). SLC7A10 is the only GWST gene downregulated by the T2D risk allele (and hence the only transcript showing anticorrelated expression levels within the GWST genes). This pattern is consistent with the known ability of the KLF family of transcription factors to act as both transcription activators and repressors 6 .
We obtained further support for the hypothesis that the trans effects are mediated by KLF14 expression from analysis of transcription factor binding sites in trans-associated genes using PSCAN 7 with the JASPAR database 8 . KLF14 itself is not represented in JASPAR, but other KLF family members have closely related binding sites (and in some cases have been shown to compete for the same binding site) 9 , and KLF4 (the only KLF family member in the JASPAR database) and KLF14 share highly similar DNA-binding C-terminal regions 10 . Though we found no evidence for enrichment after correction for multiple testing when examining the ten GWST genes alone, inclusion The effect allele is the type 2 diabetes risk allele C, which has a frequency of 55% in the HapMap CEU population. Chr., chromosome; s.e., standard error. l e t t e r s of a larger number of trans-associated genes (46 with trans P < 10 -4 or 121 with trans P < 10 -3 ) showed strong evidence of enrichment for KLF4 binding sites. KLF4 was the most over-represented binding site in the former set (Bonferroni corrected P = 0.01) and the second most over-represented site in the latter set (Bonferroni corrected P = 1.3 × 10 -7 ) after EGR1. These data indicate that one feature of the transcripts showing trans associations with the KLF14 SNPs is enrichment for KLF binding sites. Having shown that the same set of SNPs influences cis expression of KLF14, trans expression of members of the GWST gene network and a variety of metabolic traits including T2D and HDL cholesterol, we sought to clarify the causal connections between these effects and, in particular, to establish whether or not the trans effects were likely to be mediating the metabolic associations at KLF14. First, we examined the correlations between trans gene expression and concurrently measured metabolic phenotypes. At an array-wide Bonferroni threshold of P < 1.9 × 10 -6 , expression levels of six of the ten GWST genes were associated with body mass index (BMI) and HDL cholesterol, five with triglycerides, fasting insulin levels and HOMA-IR (an index of insulin sensitivity), three with adiponectin levels and two with fasting glucose ( Table 3) . Compared to all genes on the array, this represents an enrichment for expression and metabolic phenotype associations, with significance ranging from P = 0.001 to P = 3.3 × 10 -5 . The strength of these associations is consistent with a causal link between trans gene expression and metabolic phenotypes and provides clues to the biological processes in which these genes may participate.
Next, we examined large-scale association data made available by trait-specific GWAS meta-analysis consortia, focusing on SNPs in the 250-kb region surrounding each GWST gene. The rs4731702 T2D risk allele is associated with higher fasting insulin 1 , indicating that the primary effect on diabetes risk is mediated by decreased peripheral insulin sensitivity. Accordingly, we focused on a set of insulin-resistance-related traits, including fasting insulin 11 , fasting glucose 11 , HOMA-IR 11 , T2D 1 , lipids (HDL, low-density lipoprotein (LDL) and triglycerides) 2 , body fat distribution (BMIadjusted waist-hip ratio (WHR)) 12 and BMI 13 . In GWAS datasets ranging in size from 22,044 to 123,865 individuals, we found eight associations in five genes at a study-wide significance threshold of P < 1.03 × 10 -4 ( Table 4 ; see Online Methods for the threshold determination). For example, SNPs near APH1B are associated with HDL (rs2729787; P = 9.8 × 10 -9 ) and triglycerides (rs17184382; P = 1.5 × 10 -5 ), and SNPs near KLF13 are associated with BMI-adjusted WHR (rs4779526; P = 1.8 × 10 -5 ) and LDL (rs8034505; P = 5.8 × 10 -5 ). In addition, SNPs in MSRA (expression levels of which marginally failed to reach genome-wide significance; trans association P = 9.8 × 10 -8 ) have been previously associated with waist circumference 10 and are here associated with triglycerides (rs615171; P = 7.5 × 10 -7 ). This pattern of association signals shows that variation involving GWST genes has the potential to affect insulin-resistancerelated traits and thereby supports the notion that a subset of these genes are directly implicated in mediating the effects of KLF14 variation on disease susceptibility. One of the more notable transcripts identified by these analyses is SLC7A10, a member of the solute carrier family that mediates transport of neutral amino acids. Adipose expression of SLC7A10 is highly heritable (h 2 = 0.79) and is downregulated by the KLF14 T2D risk allele. SLC7A10 expression is strongly associated with diverse metabolic phenotypes, is negatively correlated with BMI (P = 3 × 10 -48 ), insulin (P = 1.1 × 10 -51 ), HOMA-IR (P = 7 × 10 -48 ), glucose (P = 6 × 10 -7 ) and triglycerides (P = 1 × 10 -34 ) and is positively correlated with HDL (P = 7 × 10 -30 ) and adiponectin (P = 1 × 10 -12 ) levels ( Table 3) . The SLC7A10 locus contains independent (r 2 = 0.03) SNPs associated with HDL (rs8182584; P = 3.2 × 10 -7 ) and BMI-adjusted WHR (rs7251505; P = 3.2 × 10 -6 ). The former SNP (rs8182584) is weakly associated with insulin levels (P = 0.002) and BMI (P = 1.4 × 10 −3 ), suggesting that this gene has a wide-ranging role in metabolism.
Our data provide convincing evidence of a bona fide adipose trans-eQTL and implicate this trans expression network in the link between KLF14 variation and risk of metabolic disease. This trans regulation uncovers new biological links between previously identified genome-wide significant associations at KLF14 (with HDL and T2D), APH1B (with HDL) and MSRA (with waist circumference) and additional signals where metabolic trait associations have not yet been established to genome-wide significance (SLC7A10, KLF13, C8orf82 and NINJ2). These links provide a framework for hypothesisdirected investigation of genetic interactions among GWAS loci and provide an example of the power of 'integrative genomics' to leverage 'omics' data from multiple sources to discover new biological and functional insights.
URLs. R, http://www.r-project.org/.
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Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/. ) were taken from a relatively photoprotected area adjacent and inferior to the umbilicus. Subcutaneous fat tissue was carefully dissected from each biopsy using forceps and a scalpel, weighed and immediately stored in liquid nitrogen. The project was approved by the local ethics committees of all institutions involved, and all samples were collected after obtaining written and signed informed consent. Metabolic phenotypes were measured at the same time point as the biopsies and were collected as previously described, including anthropometric traits (height, weight and BMI) 15 , blood lipids 16 , adiponectin 17 , fasting glucose 18 and fasting insulin 19 . The deCODE replication samples were collected as previously described 5 .
RNA extraction. RNA was extracted using TRIzol Reagent (Invitrogen) according to protocol provided by the manufacturer. Briefly, tissue samples were homogenized, and pelleted cells were lysed by repetitive pipetting. RNA quality was confirmed using the Agilent 2100 BioAnalyzer (Agilent Technologies), and the concentrations were determined using NanoDrop ND-1000 (NanoDrop Technologies).
Expression profiling. Expression profiling of the samples, each with either two or three technical replicates, were performed using the Illumina Human HT-12 V3 BeadChips (Illumina Inc.) including more than 48,000 probes, where 200 ng of total RNA was processed according to the protocol supplied by Illumina. All samples were randomized before array hybridization, and the technical replicates were always hybridized on different BeadChips. Log2-transformed expression signals were normalized with quantile normalization of the replicates of each individual followed by quantile normalization across all individuals. Post-quality-control expression profiles were obtained for 825 individuals. The Illumina probe annotations were cross-checked by mapping the probe sequence to the NCBI build 36 genome with MAQ 20 . Only the uniquely mapping probes with no mismatches and either an Ensembl or RefSeq ID were kept for analysis. Probes mapping to genes of uncertain function (LOC symbols) and those encompassing a common SNP were further excluded, leaving 23,552 probes to be used in the analysis.
Genetic association. All MuTHER eQTL associations were performed with the GenABEL and ProbABEL packages 21, 22 using both twins from each pair in a polygenic model incorporating a kinship matrix in GenABEL followed by the ProbABEL mmscore option. Age and experimental batch were included as cofactors in the analysis. Seven hundred seventy six samples had both expression profiles and genotypes. Analysis of the deCODE samples, including parent-of-origin analyses, were performed as previously described 3 .
Lead SNP selection. The trans associations did not have a single lead SNP. Each probe had barely distinguishable P values at five SNPs in high linkage disequilibrium (r 2 > 0.96, D′ = 1). Conditioning the trans associations on any of the five lead SNPs (rs13234269, rs4731702, rs972283, rs11979110 and rs13233731) completely removed the signal at the other SNPs. rs13234269 had slightly lower P values for most probes but was not present in the deCODE replication data. The lead SNP in the T2D study 1 was rs972283, and the parent-of-origin study 3 and the HDL study 2 had rs4731702 as the lead SNP.
As rs4731702 and rs972283 are in perfect linkage disequilibrium (r 2 = 1) and rs4731702 was directly genotyped in MuTHER and deCODE, whereas rs972283 was imputed in only some of the samples, we chose to report results with respect to rs4731702.
Isoform and probe differences. The Illumina HT12 array contains three probes for ARSD and PRMT2 that are designed to assay different isoforms. Expression levels measured by the two alternate probes for ARSD were not associated in trans with rs4731702 (ILMN_1684956/NM_001669, P = 0.53; ILMN_1661624/NM_009589, P = 0.13; deCODE P = 0.45 and P = 0.83, respectively), whereas one of the two PRMT2 alternate probes was associated in trans with rs4731702 (ILMN_2393544/NM_001535, P = 6.5 × 10 -4 ; ILMN_ 2259119/NM_206962, P = 0.59; no alternate probes in deCODE). The Illumina HT12 probe targeting KLF14 (ILMN_1681168) did not detect any expression in the MuTHER samples. As expression of KLF14 in adipose tissue has been previously reported in the deCODE data as well as three independent studies of adipose tissue in the GEO database 23 , we believe the apparent lack of expression in the MuTHER data is because of a technical failure of the Illumina probe. The Illumina KLF14 probe and the Agilent KLF14 probe used in the deCODE data target nonoverlapping locations in the single exon of KLF14.
Heritability. Expression heritability was calculated with a linear mixed effects model as described 24 , including age and experimental batch as covariates. All available complete twin pairs were included, corresponding to 143 monozygotic pairs and 214 dizygotic pairs. Phenotypic association. Associations between mRNA expression and phenotypes were modeled using a linear mixed effects model, using R (see URLs) and the lmer() function in the lme4 package, fitted by maximum likelihood. The linear mixed effects model was adjusted for age and experimental batch (fixed effects) and family relationship (twin pairing) and zygosity (random effects). A likelihood ratio test was used to assess the significance of the phenotype effect. The P value of the phenotype effect in each model was calculated from the χ 2 distribution with 1 degree of freedom using −2log (likelihood ratio) as the test statistic. A Fisher exact test was used to assess enrichment of phenotype associations in the GWST gene set versus the full set of genes in adipose tissue.
GWAS lookups. The ten genome-wide significant trans genes and their ~250-kb flanking regions were interrogated for SNPs associated with metabolic phenotypes in large GWAS meta-analyses 1,2,11-13 (the GIANT, MAGIC, DIAGRAM and Lipids consortia). A study-wide significance of P = 1.03 × 10 -4 was calculated by Bonferroni correcting for the 487 independents tests in the ten regions. The number of independent tests was approximated by the number of tag SNPs needed to tag all CEU HapMap SNPs with minor allele frequency (MAF) > 0.05 in the ten regions with an r 2 of 0.5 as calculated by the Tagger algorithm 25 . Alternatively, requiring an r 2 of 0.8 resulted in 880 tests for a threshold of P = 5.7 × 10 −5 . The region around ARSD was included despite the lack of X chromosome results in most studies. All genes within the ~250-kb flanking regions are listed in Supplementary Table 1 .
Transcription factor binding sites. We searched 450 bp upstream and 50 bp downstream of the transcription start site of the GWST genes for overrepresented JASPAR binding sites using PSCAN 7 .
Genotyping. Genotyping of the TwinsUK dataset (n = ~6,000) was done with a combination of Illumina arrays (HumanHap300, HumanHap610Q, 1M-Duo and 1.2MDuo 1M). Intensity data for each of the three arrays were pooled separately (with 1M-Duo and 1.2MDuo 1M pooled together), and genotypes were called with the Illuminus 26 calling algorithm, thresholding on a maximum posterior probability of 0.95. Similar exclusion criteria were applied to each of the three datasets separately. Exclusion criteria for samples were: (i) sample call rate <98%; (ii) heterozygosity across all SNPs ≥2 standard deviations from the sample mean; (iii) evidence of non-European ancestry as assessed by principal component analysis comparison with HapMap3 populations; and (iv) observed pairwise identity by descent probabilities suggestive of sample identity errors. Exclusion criteria for SNPs were: (i) Hardy-Weinberg P < 10 -6 , assessed in a set of unrelated samples; (ii) MAF < 1%, assessed in a set of unrelated samples; or (iii) SNP call rate <97% (SNPs with MAF ≥ 5%) or <99% (for 1% ≤ MAF < 5%).
Prior to merging the three datasets, we performed pairwise comparison among the three datasets and further excluded SNPs and samples as follows: (i) concordance at duplicate samples <1%; (ii) concordance at duplicate SNPs <1%; (iii) visual inspection of quantile-quantile plots for logistic regression applied to all pairwise dataset comparisons; (iv) Hardy-Weinberg P < 10 -6 ,
